Chang Gong
- Molecular Biology top 1%
- Cancer Research top 0.2%
- Oncology top 1%
- Immunology top 5%
- Epidemiology top 10%
- Topics
- MicroRNA in disease regulation (12 papers)Cancer Cells and Metastasis (11 papers)Cancer-related molecular mechanisms research (11 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Chang Gong
73 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 4.4k
- Cancer Research 3.7k
- Oncology 1.7k
- Immunology 649
- Epidemiology 452
Countries citing papers authored by Chang Gong
This map shows the geographic impact of Chang Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Gong more than expected).
Fields of papers citing papers by Chang Gong
This network shows the impact of papers produced by Chang Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Gong. The network helps show where Chang Gong may publish in the future.
Co-authorship network of co-authors of Chang Gong
This figure shows the co-authorship network connecting the top 25 collaborators of Chang Gong. A scholar is included among the top collaborators of Chang Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Gong. Chang Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 26 | |
| 6 | 20 | |
| 7 | The Effect of Low and High Vacuum Drainage on the Postoperative Drainage of Breast Cancer: Insights from a Prospective, Non-Inferiority, Randomized Clinical Trial | 2 |
| 8 | 8 | |
| 9 | 0 | |
| 10 | 27 | |
| 11 | 29 | |
| 12 | A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasisbreakdown → | 746 |
| 13 | 66 | |
| 14 | 75 | |
| 15 | 224 | |
| 16 | 211 | |
| 17 | [Analysis of BRCA1 gene mutations in patients with early-onset breast cancer and their affected relatives in Guangdong province]. | 3 |
| 18 | 15 | |
| 19 | 13 | |
| 20 | 61 |
About Chang Gong
Chang Gong is a scholar working on Cancer Research, Oncology and Otorhinolaryngology, having authored 78 papers that have together received 6.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Cancer Cells and Metastasis (11 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Cancer Research (3.7k citations), Molecular Biology (4.4k citations) and Oncology (1.7k citations). Chang Gong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Erwei Song, Herui Yao, Fengxi Su, Fengyan Yu, Bodu Liu, Xiaoqu Hu, Judy Lieberman, Pengcheng Zhu, Yijun Huang and Qiuhui Pan. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.